Authors: Bilici, Ahmet; Karaduman, Mehmet; Cankir, Zeki

Source: Scandinavian Journal of Infectious Diseases, Volume 39, Number 2, 2007 , pp. 190-192(3)

Publisher: Informa Healthcare

Abstract:

Cefprozil is a novel third generation, broad-spectrum oral cephalosporin. Serum sickness-like reaction and rash caused by cefprozil have been previously reported, but liver damage has not been documented. We report on a 15 years-old female with tonsillopharyngitis who developed hepatitis after treatment with cefprozil. Following discontinuation of cefprozil therapy, her liver functions returned to normal limits within four weeks. We suggest that for patients presenting with hepatitis associated with drugs, Cefprozil should be considered in the differential diagnosis of hepatitis.

Document Type: Research article

DOI: http://dx.doi.org/10.1080/00365540600823235

Affiliations: 1: From the Department of Internal Medicine, Etimesgut Military Hospital, Ankara, Turkey

Publication date: 2007-01-01

More about this publication?

• Information for Authors
• Subscribe to this Title
• Terms & Conditions
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Internal Medicine ,  Public Health
• By this author: Bilici, Ahmet ;  Karaduman, Mehmet ;  Cankir, Zeki

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers